Sarah Johnson is Head of regulatory and clinical affairs at SPD Development Company Ltd. Since joining Clearblue in 1999, she had gained over 15 years of experience in the medical devices industry, initially in research and more recently in clinical and regulatory affairs. She has over 15 peer reviewed publications in women’s health. She now leads the clinical and regulatory affairs and statistics departments for SPD. Clinical affairs involve the management of clinical and laboratory research connected with biomarkers of women’s health, and their application to medical devices. Recent important studies include the US based gestational age study and the UK based stress study, early pregnancy studies and fertility monitor usage studies. Regulatory affairs oversees the international registration of SPD’s products, with successful registrations in USA, Europe, Australia, Russia, China, Brazil and many other countries. Sarah Johnson is Head of regulatory and clinical affairs at SPD Development Company Ltd. Since joining Clearblue in 1999, she had gained over 15 years of experience in the medical devices industry, initially in research and more recently in clinical and regulatory affairs. She has over 15 peer reviewed publications in women’s health. She now leads the clinical and regulatory affairs and statistics departments for SPD. Clinical affairs involve the management of clinical and laboratory research connected with biomarkers of women’s health, and their application to medical devices. Recent important studies include the US based gestational age study and the UK based stress study, early pregnancy studies and fertility monitor usage studies. Regulatory affairs oversees the international registration of SPD’s products, with successful registrations in USA, Europe, Australia, Russia, China, Brazil and many other countries.

Reproductive Medicine